Company: PTHS
Filing Date: 2025-09-16
Form Type: 8-K/A
Source: 0001753926-25-001500
Chunk: 108

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-16
Form: 8-K/A
Chunk 108
---
 other natural persons who render bona fide services (not in connection with the offer or sale of securities in a capital-raising transaction and not directly or indirectly promoting or maintaining a market for the Company’s securities) to the Company are eligible to participate in the Amended and Restated 2023 Plan.

Types of Awards

The Amended and Restated 2023 Plan provides for the following types of awards granted with respect to shares of Common Stock:

| • | incentive                                                          
 and nonqualified stock options to purchase shares of Common Stock; |

| • | stock                                                         
 appreciation rights, whether settled in cash or Common Stock; |

| • | direct                                                                       
 awards or sales of shares of Common Stock, with or without restrictions; and |

| • | restricted   
 stock units. |

The recipient of an award under the Amended and Restated 2023 Plan is referred to as a participant.

Options.The Compensation Committee may grant incentive stock options (“ISOs”) and nonqualified stock options (“NSOs”) under the Amended and Restated 2023 Plan. The Compensation Committee determines the number of shares of Common Stock subject to each option, its exercise price, its duration and the manner and time of exercise; provided, however, that no option may be issued under the Amended and Restated 2023 Plan with an exercise price that is less than the fair market value of our Common Stock as of the date the option is granted, and no option issued as an ISO will have a duration that exceeds ten years. ISOs may be issued only to the Company’s employees or employees of its corporate subsidiaries, and in the case of a more than ten percent stockholder, must have an exercise price that is at least 110% of the fair market value of Common Stock as of the date the option is granted, and may not have a duration of more than five years.

The Compensation Committee, in its discretion, may provide that any option is subject to vesting limitations that make it exercisable during its entire duration or during any lesser period of time.

The
exercise price of an option may be paid (i) in cash or check, (ii) by delivery of a recourse promissory note secured by Common
Stock acquired upon exercise of the option (if approved by the Compensation Committee, except that such a loan would not be available
to any of the Company’s executive officers or directors), (iii) by means of a “cashless exercise” procedure in
which a broker transmits to us the exercise price in